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Abstract Long-term efficacy of percutaneous coronary intervention (PCI) to treat coronary heart disease is 
hampered by incidence of in-stent restenosis (ISR). The regrowth of a healthy endothelial layer post-
treatment, a key factor in successful vascular repair, has been shown to be affected by the high sensitivity of 
endothelial cells (EC) to shear stress. Characterisation of stented artery haemodynamics is required to 
understand the response of EC to complex flow and shear stress patterns induced by stent structure. A device 
for the in vitro study of coronary stents has been developed and fabricated in polydimethylsiloxane (PDMS). 
Balloon-mounted cobalt-chromium stents have been successfully deployed, and particle tracking has been 
employed to obtain streamlines under low flow rate. High-resolution flow-patterns can be imaged, and 
complemented with in silico analysis from µCT data. The device allows for the seeding of EC, and sustained 
exposure to shear stress. EC response can be investigated by comparing real-time footage of cellular 
migration and proliferation to the haemodynamics of the specific region. 
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1. Introduction 
 
 Coronary heart disease is the leading cause 
of death worldwide, claiming 7 million lives 
annually (Mackay et al, 2004). Minimally 
invasive treatments are available to alleviate 
symptoms caused by atherosclerosis and 
stenosis, the narrowing and blocking of 
arteries. Percutaneous coronary intervention 
(PCI) widens stenosed arteries with inflatable 
balloon catheters, with the subsequent 
insertion of stents to act as supporting 
scaffolds. However, PCI with bare metal stents 
(BMS) has been associated with rates of 
ensuing in-stent restenosis of up to 44% 
(Farooq et al, 2011). Globally, more than 1.5 
million people receive stents each year 
(McFadden et al, 2004). Optimising stented 
artery repair would reduce mortality and 
improve quality of life. 
 The development of ISR is initiated by 
denudation of the endothelium, the vessel’s 
cellular lining, by balloon and stent expansion. 
This injury, in addition to the presence of the 
stent as a foreign body, leads to inflammation, 
migration of smooth muscle cells (SMC), 
neointimal hyperplasia, and ultimately ISR; 
defined as >50% reduction of luminal diameter 
(Kuntz et al, 1992). 
 Accordingly, several factors are deemed 
central in reducing ISR incidence: minimising 
the impact of stent deployment through 
considered design (Sangiorgi et al, 2007); 
reducing inflammation and SMC proliferation; 
minimising EC loss and promoting the 
regeneration of a healthy endothelium (Hamid 
and Coltart, 2007). 
 
 Current technological trends for improved 
stent performance focus on drug-eluting stents 
(DES), which release anti-proliferative agents 
to inhibit SMC and neointimal growth. While 
DES have been shown to reduce rates of ISR 
(Farooq et al, 2011), anti-proliferatives also 
act to inhibit endothelial repair (Chaabane et 
al, 2013). Furthermore, as peak neointimal 
growth is seen at 6-12 months post-treatment 
(Virmani et al, 2003), polymer coatings are 
required to reduce rates of elution, which are 
themselves known to cause inflammation 
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(Bangalore et al, 2013). 
 More recently, fully bioabsorbable stents 
have been developed and clinically trialled. 
Guidance on their use in the UK is due in May 
2014 (National Institute for Health and Care 
Excellence, 2014), however, shortcomings 
have been noted (Waksman, 2006). Thicker, 
more impactful bioabsorbable polymer 
structures are required to provide the same 
stiffness as BMS, and ISR may still occur in 
the months prior to full dissolution. 
  
 A third approach considers the mechanical, 
haemodynamic environment of the stent/artery 
system. As described by Van der Heiden et al 
(2013), EC mechanoreceptors react to blood 
flow induced shear stress, differentiating 
between variations in magnitude and direction. 
 Low (0-4 dynes/cm
2
 [0-0.4 Pa]) (Malek et 
al, 1999; Duraiswamy et al, 2007) or 
oscillatory shear stress inhibits 
reendothelialisation, with EC migration away 
from areas of significant shear stress gradient, 
consistent with the observation that regions of 
low shear stress, such as bifurcations, are 
particularly prone to atherosclerosis (Hoefer et 
al, 2013). 
 Conversely, high (~15 dynes/cm
2
 [1.5 Pa]) 
(Sprague et al, 1997; Duraiswamy et al, 2007), 
uniform shear stress supports a healthy 
endothelium and conveys protective effects: 
the activation of genes reducing inflammation 
and thrombus formation, the inhibition of 
SMC proliferation (Ueba et al, 1997) and 
reduction of neointimal hyperplasia. 
 Promoting high, uniform shear stress and 
minimising areas of low or oscillatory shear 
stress should therefore be considered during 
efforts to prevent ISR. Full characterisation of 
the stented artery is required to understand the 
influence of shear stress on the endothelium 
and vascular repair. 
 
 Initial studies of stent structures used 
simple models. For example, Sprague et al 
(1997) implanted metal coupons on collagen 
gels which were seeded with EC and exposed 
to various flow conditions. While such 
techniques effectively illustrate the effect of 
shear stress, and have been more recently 
reemployed by Sprague et al (2012) to 
evaluate patterned stent surfaces, replication of 
the entire stent mesh and the vessel’s tubular 
structure is necessary. 
 Benbrahim et al (1994; 1996) and Moore et 
al (1994) fabricated tubular structures within 
which EC were exposed to haemodynamic 
forces, and increasingly realistic vascular 
models have since been developed. Both 
realistic pulsatile flow (Peng et al, 2000) and 
the combined action of multiple forces 
(O’Cearbhaill et al, 2008) have been 
introduced. 
 Punchard et al built upon their own 
previous work, creating a silicone tube to 
assess seeded EC under haemodynamic 
conditions (2007), to create one of the first in 
vitro models into which a stent was deployed 
(2009). The device demonstrates an 
experimental approach required to assess the 
behavior of EC within the stented artery, 
although the assessment is limited to a single, 
static examination which necessitates 
destruction of the model. 
 
 This work aims to create a technique by 
which repeated use in vitro and in silico 
models can be utilised in combination to 
characterise the haemodynamics of complex 
stent structures; to observe the effects of 
modified shear stress on EC migration and 
proliferation in real-time; and to compare, 
quantify and predict the effects of commercial 
stent design on endothelial repair. 
 
2. Materials and methods 
 
In vitro model 
 
 Moulds were created by threading 80mm 
long straight sections of fluorinated ethylene 
propylene (FEP) tubing through the walls of 
56mm diameter Petri dishes. 2mm and 3mm 
diameter tubing represented typical diameters 
of coronary arteries (Dodge et al, 1992). 
 PDMS (Sylgard 184, Dow Corning Corp., 
Midland, USA) was prepared by mixing base 
and curing agent at a 10:1 ratio by weight, and 
degassing in a vacuum desiccator. 22g was 
poured into each mould and cured, to create 
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9mm thick silicone elastomer blocks 
containing channels of circular cross-section. 
 Balloon catheters were guided into the 
tubular channels and inflated to deploy ready-
mounted cobalt-chromium alloy stents (kindly 
contributed by the Royal Hallamshire 
Hospital, Sheffield). Stents of 8mm, 16mm 
and 19mm length, and 4mm nominal diameter 
were deployed. Inflation at 6 atm, to the 
minimum stated balloon diameter of 3.39mm, 
allowed catheters within 3mm diameter 
channels to meet the ‘gold standard’ balloon to 
artery ratio of 1.1 – 1.2:1. Catheters were 
withdrawn, and inspection under a microscope 
confirmed adequate stent expansion. 
 Stented channels are connected, via 
additional FEP tubing, to fluid reservoirs and a 
peristaltic pump to provide a constant pulsatile 
unidirectional flow. In addition to the 
appropriate selection of channel diameter and 
stent deployment procedure, flow rate and 
associated shear stress can be adjusted to attain 
conditions comparable to those in vivo. 
 Flow rates required to achieve desired 
levels of mean wall shear stress (τmean) were 
calculated using the Hagen-Poiseuille 
equation: 
 
 
where Q is the volumetric flow rate, µ the 
dynamic viscosity of the fluid and r the 
internal radius of the channel. Reynolds 
numbers were found, and used to confirm that 
channel entrance lengths were long enough for 
the flow to fully develop before reaching stent 
leading edges. 
 Initial testing was conducted at low shear 
stress levels, not exceeding 1 dyne/cm
2
 (0.1 
Pa), by applying a maximum flow rate of 5 
ml/min (2mm diameter channel) and 16 
ml/min (3mm diameter channel). 
 
Flow imaging 
 
 The optical transparency of PDMS allows 
direct observation of fluid flow around the 
stent in situ. 1µl of 10µm diameter 
FluoSpheres (Life Technologies, Carlsbad, 
USA) was added to 10ml of room temperature 
deionised water and subsequently used to 
image the flow using light and fluorescent 
microscopy. A number of video recordings 
were made with 4x, 10x, 20x and 40x 
objective lenses at various locations on the 
stent mesh, including entry and exit. 
 Flow patterns and streamlines were 
obtained by separating recordings into their 
constituent frames and manually tracking 
particles between them. Image scale and frame 
rates were used to extrapolate rough velocity 
profiles. 
 
In silico model 
 
 In silico analysis of the stented channels 
using computational fluid dynamic models is 
performed from in vitro devices. Models are 
created from images obtained by micro 
computed tomography (µCT). 
 A SkyScan 1172 µCT scanner (Bruker, 
Billerica, USA) is used to obtain virtual cross-
sectional slices of expanded stents. This raw 
data, with 7.86µm voxel resolution, can then 
be processed to reconstruct a 3D model. 
 Although the wall of the tube may be 
imaged, omitting the PDMS minimizes 
artefacts and allows the extraction and 
reconstruction of a more precise model of the 
stent. The arterial wall will be recreated in 
finite element software (Morlacchi et al, 
2011), and the model imported into 
computational fluid dynamics software for 
analysis. 
 
 
Figure 1: Structural detail of deployed stent 
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Figure 2: Tracked particle streamlines around stent struts. 4ml/min flow, left to right, 0.8 
dynes/cm
2
 (0.08 Pa). Scale bars: 100 µm. 
 
3. Results 
 
 PDMS blocks containing circular channels 
were fabricated, and stents were successfully 
deployed. Visual inspection confirmed 
expansion and insertion into the channel wall. 
The structure of the expanded stent is 
illustrated in Fig. 1. 65µm struts are arranged 
in repeating offset peak-to-valley rings, 
connected by 3 bridges. The channels were 
readily connected to the reservoir and pump, 
and a range of low, physiologically 
comparable flows were applied. 
 Particle flow was visible under all 
magnifications. Light microscopy was 
favoured, as fluorescent microscopy did not 
show the local stent structure as a reference. A 
substantial velocity gradient was observed, 
fitting the profile expected of laminar pipe 
flow, i.e. increasing away from the wall. 
 Particles were seen to be influenced by the 
presence of the stent within ~150µm of the 
structure. As shown in Fig. 2, deviation from a 
laminar stream is revealed as particles are 
tracked along struts. Turbulent flow is further 
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Figure 3: Estimated particle velocity profiles extracted from tracking data (blue streamline). 
4ml/min flow, left to right, 0.8 dynes/cm
2
 (0.08 Pa). Inset (b.) highlights area of particle 
accumulation. 
 
 
Figure 4: 3D reconstruction of stent from µCT data. 8mm long stent expanded to 3.39mm, within 
3mm diameter channel. 
 
indicated by deceleration towards, and 
acceleration away from, circumferentially 
orientated struts (Fig. 3). In some sites, 
particularly valleys in the ring structure, 
particles began to accumulate (Fig. 3 b.). 
Further observation and CFD may confirm 
whether these are areas of recirculation or 
stagnation points due to strut protrusion into 
the lumen. 
 µCT provided high-resolution data with 
minimal issue from image artefacts, from 
which a 3D model was reconstructed (Fig. 4). 
 
3. Conclusion 
 
 We have created a novel microfluidic 
system for the study of stented arteries, 
recognizing the need for greater understanding 
of the system’s mechanobiology. The use of 
PDMS rapid prototyping provided a 
customisable, cost- and time-efficient in vitro 
model. This allows high-throughput 
investigation of simple vascular anatomy, with 
the potential for modelling more complex 
structures, e.g. bifurcations and branch points. 
 In addition, the optical transparency of 
PDMS allowed the direct observation of flow 
using FluoSphere particles, demonstrating the 
complex patterns generated by stent structures. 
 Particle tracking velocimetry illustrated 
variable planar velocity; however, the method 
was not relied upon to provide quantitative 
data. The degree of uncertainty associated with 
scaling, the commercial recording and video-
to-image conversion software, and human 
error in tracking was too great. The approach 
may be refined, although further work will 
indicate whether this current technique is at all 
practical when applied to the greater flow rates 
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required to test higher shear stress levels. 
 Particle tracking highlighted the benefit of 
performing CFD analysis in conjunction with 
in vitro modelling, for more accurate, 
quantitative results from three-dimensional 
data. 
 Following proof-of-concept presented here, 
the microfluidic system and biological 
compatibility of PDMS will enable the seeding 
and direct analysis of EC. Continuous flow of 
cell culture media around deployed stents, 
within the controlled environment of a 
microscope incubator, will allow migration 
and proliferation of EC to be observed first 
hand. 
 In vitro and in silico analysis can provide 
fluid dynamics data of far greater resolution 
that that possible with in vivo study, and real-
time cellular monitoring improves on 
retrospective ex vivo examination. This 
combination will aid the full characterisation 
of stented artery haemodynamics over a 
greater range of shear stress levels, and the 
quantitative assessment and comparison of 
commercial stent designs. 
 Finally, this method could also be used for 
the development of new generations of DES, 
aligning drug diffusion patterns to observable 
effects on seeded EC. Assessment of the 
effects of shear stress on the dissolution of 
biodegradable stents and evaluation of the risk 
of embolism from non-uniform degradation 
are further examples of potential future 
applications of such research. 
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